282 related articles for article (PubMed ID: 12055083)
1. Oxidative stress inactivates the human DNA mismatch repair system.
Chang CL; Marra G; Chauhan DP; Ha HT; Chang DK; Ricciardiello L; Randolph A; Carethers JM; Boland CR
Am J Physiol Cell Physiol; 2002 Jul; 283(1):C148-54. PubMed ID: 12055083
[TBL] [Abstract][Full Text] [Related]
2. DNA mismatch repair enzyme activity and gene expression in prostate cancer.
Yeh CC; Lee C; Dahiya R
Biochem Biophys Res Commun; 2001 Jul; 285(2):409-13. PubMed ID: 11444857
[TBL] [Abstract][Full Text] [Related]
3. Loss of mismatch repair activity in simian virus 40 large T antigen-immortalized BPH-1 human prostatic epithelial cell line.
Yeh CC; Lee C; Huang MC; Dahiya R
Mol Carcinog; 2001 Jul; 31(3):145-51. PubMed ID: 11479923
[TBL] [Abstract][Full Text] [Related]
4. N-terminus of hMLH1 confers interaction of hMutLalpha and hMutLbeta with hMutSalpha.
Plotz G; Raedle J; Brieger A; Trojan J; Zeuzem S
Nucleic Acids Res; 2003 Jun; 31(12):3217-26. PubMed ID: 12799449
[TBL] [Abstract][Full Text] [Related]
5. Mismatch repair and microsatellite instability in esophageal cancer cells.
Uchida N; Kumimoto H; Nishizawa K; Tokumasu S; Harada H; Shimada Y; Ishizaki K
Int J Cancer; 2001 Mar; 91(5):687-91. PubMed ID: 11267981
[TBL] [Abstract][Full Text] [Related]
6. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability testing in colorectal carcinoma: choice of markers affects sensitivity of detection of mismatch repair-deficient tumors.
Hatch SB; Lightfoot HM; Garwacki CP; Moore DT; Calvo BF; Woosley JT; Sciarrotta J; Funkhouser WK; Farber RA
Clin Cancer Res; 2005 Mar; 11(6):2180-7. PubMed ID: 15788665
[TBL] [Abstract][Full Text] [Related]
8. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
9. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.
Brieger A; Trojan J; Raedle J; Plotz G; Zeuzem S
Gut; 2002 Nov; 51(5):677-84. PubMed ID: 12377806
[TBL] [Abstract][Full Text] [Related]
10. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
[TBL] [Abstract][Full Text] [Related]
11. Mutations within the hMLH1 and hPMS2 subunits of the human MutLalpha mismatch repair factor affect its ATPase activity, but not its ability to interact with hMutSalpha.
Räschle M; Dufner P; Marra G; Jiricny J
J Biol Chem; 2002 Jun; 277(24):21810-20. PubMed ID: 11948175
[TBL] [Abstract][Full Text] [Related]
12. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
[TBL] [Abstract][Full Text] [Related]
13. The interaction of DNA mismatch repair proteins with human exonuclease I.
Schmutte C; Sadoff MM; Shim KS; Acharya S; Fishel R
J Biol Chem; 2001 Aug; 276(35):33011-8. PubMed ID: 11427529
[TBL] [Abstract][Full Text] [Related]
14. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.
Cunningham JM; Kim CY; Christensen ER; Tester DJ; Parc Y; Burgart LJ; Halling KC; McDonnell SK; Schaid DJ; Walsh Vockley C; Kubly V; Nelson H; Michels VV; Thibodeau SN
Am J Hum Genet; 2001 Oct; 69(4):780-90. PubMed ID: 11524701
[TBL] [Abstract][Full Text] [Related]
15. Conditional nuclear localization of hMLH3 suggests a minor activity in mismatch repair and supports its role as a low-risk gene in HNPCC.
Korhonen MK; Raevaara TE; Lohi H; Nyström M
Oncol Rep; 2007 Feb; 17(2):351-4. PubMed ID: 17203173
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer.
Fallik D; Borrini F; Boige V; Viguier J; Jacob S; Miquel C; Sabourin JC; Ducreux M; Praz F
Cancer Res; 2003 Sep; 63(18):5738-44. PubMed ID: 14522894
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of human mismatch repair genes in adult T-cell leukemia.
Morimoto H; Tsukada J; Kominato Y; Tanaka Y
Am J Hematol; 2005 Feb; 78(2):100-7. PubMed ID: 15682421
[TBL] [Abstract][Full Text] [Related]
18. Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation.
Plaschke J; Krüger S; Pistorius S; Theissig F; Saeger HD; Schackert HK
Int J Cancer; 2002 Feb; 97(5):643-8. PubMed ID: 11807791
[TBL] [Abstract][Full Text] [Related]
19. Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck.
Nunn J; Nagini S; Risk JM; Prime W; Maloney P; Liloglou T; Jones AS; Rogers SR; Gosney JR; Woolgar J; Field JK
Oral Oncol; 2003 Feb; 39(2):115-29. PubMed ID: 12509964
[TBL] [Abstract][Full Text] [Related]
20. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
Jacob S; Aguado M; Fallik D; Praz F
Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]